A Chance to Catch the Market With Biotech ETFs

dougsandlerDoug Sandler, of the Riverfront Investment Group, thinks biotech is set to go higher after earnings season and could be an investor’s chance to play catch-up. Doug draws a correlation between biotech and the technology sector. With the recent run in Technology, Doug thinks that biotech has lagged behind, and has room to catch up. Doug warns that in the biotech sector, there is a tendency to be either a blow up or a home run, with blow ups more of the norm. He thinks that ETF’s are the way to play the potential growth, as you are given diversification to many different companies.

See his interview with CNBC below:


Leave a Reply

Your email address will not be published. Required fields are marked *